These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25802031)

  • 1. Innovative clinical trial designs to rationalize TB vaccine development.
    Ellis RD; Hatherill M; Tait D; Snowden M; Churchyard G; Hanekom W; Evans T; Ginsberg AM
    Tuberculosis (Edinb); 2015 May; 95(3):352-7. PubMed ID: 25802031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults.
    Nicol MP; Grobler LA
    Curr Opin Mol Ther; 2010 Feb; 12(1):124-34. PubMed ID: 20140824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of TB vaccines: harmonization and cooperation.
    Mahomed H; Fourie PB
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S21-4. PubMed ID: 22441155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspective in tuberculosis vaccine development for high TB endemic regions.
    Husain AA; Daginawala HF; Singh L; Kashyap RS
    Tuberculosis (Edinb); 2016 May; 98():149-58. PubMed ID: 27156631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing tuberculosis vaccine efficacy trials - lessons from recent studies.
    Ginsberg AM
    Expert Rev Vaccines; 2019 May; 18(5):423-432. PubMed ID: 30892969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational approach to selection and clinical development of TB vaccine candidates.
    Barker L; Hessel L; Walker B
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S25-9. PubMed ID: 22441156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01
    Ullah I; Bibi S; Ul Haq I; Safia ; Ullah K; Ge L; Shi X; Bin M; Niu H; Tian J; Zhu B
    Front Immunol; 2020; 11():1806. PubMed ID: 33133057
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventive vaccines for tuberculosis.
    Evans TG; Brennan MJ; Barker L; Thole J
    Vaccine; 2013 Apr; 31 Suppl 2():B223-6. PubMed ID: 23598486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging adolescents in tuberculosis and clinical trial research through drama.
    Schmidt BM; Abrams A; Tameris M
    Trials; 2016 Apr; 17():177. PubMed ID: 27048474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis vaccines and prevention of infection.
    Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
    Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies of TB vaccines.
    Hawkridge A
    Hum Vaccin; 2009 Nov; 5(11):773-6. PubMed ID: 19684467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccine development: Shifting focus amid increasing development challenges.
    Graves AJ; Hokey DA
    Hum Vaccin Immunother; 2015; 11(8):1910-6. PubMed ID: 26125249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.